首站-论文投稿智能助手
典型文献
Distal mutation V486M disrupts the catalytic activity of DPP4 by affecting the flap of the propeller domain
文献摘要:
Dipeptidyl peptidase-4(DPP4)plays a crucial role in regulating the bioactivity of glucagon-like peptide-1(GLP-1)that enhances insulin secretion and pancreatic β-cell proliferation,making it a therapeutic target for type 2 diabetes.Although the crystal structure of DPP4 has been determined,its structure-function mechanism is largely unknown.Here,we examined the biochemical properties of sporadic human DPP4 mutations distal from its catalytic site,among which V486M ablates DPP4 dimerization and causes loss of enzymatic activity.Unbiased molecular dynamics simulations revealed that the distal V486M mutation induces a local conformational collapse in a β-propeller loop(residues 234-260,defined as the flap)and disrupts the dimerization of DPP4.The"open/closed"conformational transitions of the flap whereby capping the active site,are involved in the enzymatic activity of DPP4.Further site-directed mutagenesis guided by theoretical predictions verified the importance of the conformational dynamics of the flap for the enzymatic activity of DPP4.Therefore,the current studies that combined theoretical modeling and experimental identification,provide important insights into the biological function of DPP4 and allow for the evaluation of directed DPP4 genetic mutations before initiating clinical applications and drug development.
文献关键词:
作者姓名:
Teng-teng Li;Cheng Peng;Ji-qiu Wang;Zhi-jian Xu;Ming-bo Su;Jia Li;Wei-liang Zhu;Jing-ya Li
作者机构:
State Key Laboratory of Drug Research,the National Drug Screening Center,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;School of Life Science and Technology,ShanghaiTech University,Shanghai 201210,China;CAS Key Laboratory of Receptor Research;Drug Discovery and Design Center,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Schoolof Pharmacy,University of Chinese Academy of Sciences,Beijing 100049,China
引用格式:
[1]Teng-teng Li;Cheng Peng;Ji-qiu Wang;Zhi-jian Xu;Ming-bo Su;Jia Li;Wei-liang Zhu;Jing-ya Li-.Distal mutation V486M disrupts the catalytic activity of DPP4 by affecting the flap of the propeller domain)[J].中国药理学报(英文版),2022(08):2147-2155
A类:
V486M,ablates,Unbiased
B类:
Distal,disrupts,catalytic,DPP4,affecting,flap,propeller,domain,Dipeptidyl,peptidase,plays,crucial,role,regulating,bioactivity,glucagon,like,peptide,GLP,that,enhances,insulin,secretion,pancreatic,cell,proliferation,making,therapeutic,target,type,diabetes,Although,crystal,structure,has,been,determined,its,function,mechanism,largely,unknown,Here,we,examined,biochemical,properties,sporadic,human,mutations,distal,from,site,among,which,dimerization,causes,loss,enzymatic,molecular,dynamics,simulations,revealed,induces,local,conformational,collapse,loop,residues,defined,open,closed,transitions,whereby,capping,active,are,involved,Further,directed,mutagenesis,guided,theoretical,predictions,verified,importance,Therefore,current,studies,combined,modeling,experimental,identification,provide,important,insights,into,biological,allow,evaluation,genetic,before,initiating,clinical,applications,drug,development
AB值:
0.578938
相似文献
Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases
Qing Wang;Li-Juan Song;Zhi-Bin Ding;Zhi Chai;Jie-Zhong Yu;Bao-Guo Xiao;Cun-Gen Ma-Research Center of Neurobiology,The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine,Shanxi University of Chinese Medicine,Jinzhong,Shanxi Province,China;Department of Physiology,Shanxi Medical University,Taiyuan,Shanxi Province,China;Institute of Brain Science,Shanxi Key Laboratory of Inflammatory Neurodegenerative Diseases,Shanxi Datong University,Datong,Shanxi Province,China;Department of Neurology,Datong Fifth People's Hospital,Datong,Shanxi Province,China;Institute of Neurology,Huashan Hospital,Institutes of Brain Science and State Key Laboratory of Medical Neurobiology,Fudan University,Shanghai,China
Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners
Zhao Simin;Zheng Baisong;Wang Liuli;Cui Wenzhe;Jiang Chunlai;Li Zhuo;Gao Wenying;Zhang Wenyan-Center for Pathogen Biology and Infectious Diseases, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China;College of Life Science of Jilin University, Changchun, Jilin 130012, China;Department of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130012, China;Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, China;Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, China
Identification of sitagliptin binding proteins by affinity purification mass spectrometry
Xue-Ning Wang;Byu-Ri Sim;Hong Chen;Yun-Xiao Zheng;Jun-Biao Xue;Lei Wang;Wei-Sha Kong;Kuan Zhou;Shu-Juan Guo;Jing-Li Hou;Jiong Zhang;He-Wei Jiang;Sheng-Ce Tao-Shanghai Center for Systems Biomedicine,Key Laboratory of Systems Biomedicine(Ministry of Education),Shanghai Jiao Tong University,Shanghai 200240,China;State Key Laboratory of Microbial Metabolism,Joint International Research Laboratory of Metabolic and Developmental Sciences,MOE-LSB&MOE-LSC,School of Life Sciences and Biotechnology,Shanghai Jiao Tong University,Shanghai 200240,China;Instrumental Analysis Center,Shanghai Jiao Tong University,Shanghai 200240,China,41nflammation and Immune Mediated Diseases Laboratory of Anhui Province,School of Pharmacy,Anhui Medical University,Hefei 230032,China;Key Laboratory of Organofluorine Chemistry,Center for Excellence in Molecular Synthesis,Shanghai Institute of Organic Chemistry,University of the Chinese Academy of Sciences,Chinese Academy of Sciences,Shanghai 200032,China.
The structure of erastin-bound xCT-4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis
Renhong Yan;Enjun Xie;Yaning Li;Jin Li;Yuanyuan Zhang;Ximin Chi;Xueping Hu;Lei Xu;Tingjun Hou;Brent R.Stockwell;Junxia Mini;Qiang Zhou;Fudi Wang-Westlake Laboratory of Life Sciences and Biomedicine,Key Laboratory of Structural Biology of Zhejiang Province,Institute of Biology,Westlake Institute for Advanced Study,School of Life Sciences,Westlake University,Hangzhou,Zhejiang,China;Department of Biochemistry,School of Medicine,Southern University of Science and Technology,Shenzhen,Guangdong,China;The First Affiliated Hospital,The Fourth Affiliated Hospital,School of Public Health,Institute of Translational Medicine,Cancer Center,State Key Laboratory of Experimental Hematology,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;The First Affiliated Hospital,The Second Affiliated Hospital,Basic Medical Sciences,School of Public Health,Hengyang Medical School,University of South China,Hengyang,Hunan,China;Beijing Advanced Innovation Center for Structural Biology,Tsinghua-Peking Joint Center for Life Sciences,School of Life Sciences,Tsinghua University,Beijing,China;Hangzhou Institute of Innovative Medicine,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou,Zhejiang,China;Institute of Bioinformatics and Medical Engineering,Jiangsu University of Technology,Changzhou,Jiangsu,China;Department of Biological Sciences and Department of Chemistry,Columbia University,New York,NY,USA
Structures of the endogenous peptide-and selective non-peptide agonist-bound SSTR2 signaling complexes
Li-Nan Chen;Wei-Wei Wang;Ying-Jun Dong;Dan-Dan Shen;Jia Guo;Xuefei Yu;Jiao Qin;Su-Yu Ji;Huibing Zhang;Qingya Shen;Qiaojun He;Bo Yang;Yan Zhang;Qinglin Li;Chunyou Mao-Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital,Zhejiang University,School of Medicine,Hangzhou,Zhejiang,China;Department of General Surgery,Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Center for Structural Pharmacology and Therapeutics Development,Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Liangzhu Laboratory,Zhejiang University Medical Center,Hangzhou,Zhejiang,China;The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital),Hangzhou,Zhejiang,China;Zhejiang Province Key Laboratory of Anti-Cancer Drug Research,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou,Zhejiang,China;MOE Frontier Science Center for Brain Research and Brain-Machine Integration,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;Zhejiang Provincial Key Laboratory of Immunity and Inflammatory diseases,Hangzhou,Zhejiang,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。